First Time Loading...
S

Shanghai Junshi Biosciences Co Ltd
SSE:688180

Watchlist Manager
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Watchlist
Price: 30.14 CNY 7.84% Market Closed
Updated: Apr 30, 2024

Shanghai Junshi Biosciences Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Junshi Biosciences Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Junshi Biosciences Co Ltd
SSE:688180
Cash from Operating Activities
-¥2B
CAGR 3-Years
-11%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-¥7.8B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Operating Activities
-¥1.7B
CAGR 3-Years
-78%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
¥1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Operating Activities
¥2.5B
CAGR 3-Years
37%
CAGR 5-Years
55%
CAGR 10-Years
34%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
¥3.6B
CAGR 3-Years
3%
CAGR 5-Years
106%
CAGR 10-Years
47%

See Also

What is Shanghai Junshi Biosciences Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-2B CNY

Based on the financial report for Dec 31, 2023, Shanghai Junshi Biosciences Co Ltd's Cash from Operating Activities amounts to -2B CNY.

What is Shanghai Junshi Biosciences Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-31%

Over the last year, the Cash from Operating Activities growth was -13%. The average annual Cash from Operating Activities growth rates for Shanghai Junshi Biosciences Co Ltd have been -11% over the past three years , -31% over the past five years .